BIOLIFE SOLUTIONS INC

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

Price chart

Open-market purchases and sales by BLFS insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
May 21, 20267:10 PM ETMay 19 – May 21, 2026Casdin Partners GP, LLC and 3 others10% OwnerSSaleCommon Stock, par value $0.001 per share−1.2M$23.4375−$28.13M4.76M−20.1%SEC
Mar 31, 2026Mar 23, 2026Foster Karen A.Chief Quality and OperationsSSaleCommon Stock−2.58K$19.17−$49.4K108.76K−2.3%SEC10b5-1
Mar 9, 2026Mar 5 – Mar 9, 2026Foster Karen A.Chief Quality and OperationsSSaleCommon Stock−97.42K$20.1492−$1.96M113.24K−46.2%SEC
Mar 5, 2026Mar 3, 2026Werner SeanChief Technology OfficerSSaleCommon Stock−111$20.74−$2.3K49.93K−0.2%SEC10b5-1
Mar 5, 2026Mar 3, 2026Foster Karen A.Chief Quality and OperationsSSaleCommon Stock−418$20.74−$8.67K210.67K−0.2%SEC10b5-1

The largest institutional positions in BLFS at the end of Q2 2026.

Institutions holding BLFS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
T. Rowe Price Investment Management, Inc.6,751,135$190.65M0.12%+244,789+3.8%Added
BlackRock, Inc.6,375,545$180.05M0.00%+273,780+4.5%Added
Casdin Capital, LLC4,655,000$131.46M6.58%−1,302,165−21.9%Reduced
Invesco Ltd.2,240,423$63.27M0.01%−108,109−4.6%Reduced
VANGUARD CAPITAL MANAGEMENT LLC1,964,084$55.47M0.00%+46,376+2.4%Added